secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viatris Inc (VTRS)
CIK:        0001792044
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001193125-23-249206
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Viatris enters agreement to sell OTC business to Cooper Consumer Health for up to €1.95B
--------------------------------------------------------------------------------

- Up to €1.95B cash consideration: €1.85B at closing plus up to €100M contingent on return multiple.
- Option exercisable by Viatris after employee consultations; expires Feb 2, 2024.
- Closing subject to regulatory approvals from EU Commission, Serbia, France, and Italy.
- Viatris to provide transition services; €25M advance payment at closing for TSA fees.
- €120M of consideration retained by buyer for future sale of select geographies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/0001193125-23-249206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/d470098d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-249206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer